JAK/STAT inhibitors mitigate sepsis‐associated cerebral and cognitive injury
Fundamental & Clinical Pharmacology · 2025
DOI: 10.1111/fcp.70005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2025. Verfasst von Mohini Singh Bhadauriya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, India. Hauptthemen laut MEDLINE: Sulfonamides, Pyrimidines, Azetidines, Cognitive Dysfunction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis is a life threatening condition which triggers multiple organ failure. Sepsis‐associated encephalopathy (SAE) is more prevalent form of sepsis which involves acute and long‐term cerebral impairment. JAK/STAT pathway is one of the most crucial signaling cascades which promote neuroinflammation.
Objectives
The present investigation was designed to explore the possible role of JAK/STAT inhibitors in sepsis‐induced cerebral injury and cognitive impairment in mice.
Methods
Swiss Albino mice underwent cecal ligation and puncture (CLP) to induce sepsis‐associated cognitive deficits. Tofacitinib and baricitinib were administered orally one hour before CLP, followed by six days post‐CLP administration. From days 7‐12, behavioral changes were assessed through various tests, including open field (locomotor activity and non‐associative memory), inhibitory avoidance (aversive memory), novel object recognition (recognition memory), and Morris‐Water maze tests (spatial learning and memory). Neuronal injury (S‐100 calcium‐binding protein B, S100B and neuronal specific enolase, NSE) and inflammation (TNF‐α) were assessed in the serum. Further, oxidative changes in the mouse brain were evaluated by measuring malondialdehyde and reduced glutathione levels.
Results
JAK/STAT inhibitors, including tofacitinib (7.5 and 15 mg/kgper os) and baricitinib (5 and 10 mg/kgper os), significantly ameliorated sepsis‐induced deficits in non‐associative, aversive, recognition and spatial memory in mice. Further, tofacitinib and baricitinib treatment decreased TNF‐α, Malondialdehyde, S‐100B and NSE in mice with sepsis while increasing the levels of reduced glutathione.
Conclusion
JAK/STAT inhibitors significantly decreased neuroinflammation, oxidative stress, and neuronal damage while enhancing cognitive function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, India.
ORCID-Profile: Anjana Bali
Förderung
- Science and Engineering Research Board
Zitieren
APA
Bhadauriya, M. S., Singh, H., Suri, M., Hanifa, M., & Bali, A. (2025). JAK/STAT inhibitors mitigate sepsis‐associated cerebral and cognitive injury. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70005
Vancouver
Bhadauriya MS, Singh H, Suri M, Hanifa M, Bali A. JAK/STAT inhibitors mitigate sepsis‐associated cerebral and cognitive injury. Fundamental & Clinical Pharmacology. 2025. doi:10.1111/fcp.70005
BibTeX
@article{Bhadauriya2025,
author = {Bhadauriya, Mohini Singh and Singh, Harshita and Suri, Manisha and Hanifa, Mohd and Bali, Anjana},
title = {JAK/STAT inhibitors mitigate sepsis‐associated cerebral and cognitive injury},
journal = {Fundamental & Clinical Pharmacology},
year = {2025},
doi = {10.1111/fcp.70005}
}
EUVIMED